Literature DB >> 17935699

Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression.

Aldric Hama1, Jacqueline Sagen.   

Abstract

Chronic pain symptoms, including spontaneous unevoked pain and evoked cutaneous hypersensitivity, appear following spinal cord injury (SCI). A reliable preclinical model is needed to develop effective analgesic treatments for these symptoms. A previously described rat model of SCI pain was modified and behaviorally characterized and used to test clinically available drugs. A segment of the mid-thoracic spinal cord was compressed for 60 s with a micro-vascular clip. The sensitivity of the hind paws to noxious heat (Hargreaves test), innocuous tactile (von Frey filaments), and cooling (acetone) stimuli were determined once per week beginning 1 week following spinal compression. Spinal cord compression led to long lasting hypersensitivity to stimuli, lasting for at least 12 weeks post-surgery. Systemic baclofen, gabapentin, tramadol, and morphine dose-dependently attenuated tactile hypersensitivity. No effect on tactile hypersensitivity was observed with amitriptyline, carbamazepine, rofecoxib, and diazepam. Baclofen and morphine also dose-dependently ameliorated heat hypersensitivity. In contrast, no effect on heat hypersensitivity was observed with amitriptyline, carbamazepine, diazepam and gabapentin. The current data suggest that the model can potentially differentiate those drugs with analgesic efficacy from those that do not have efficacy in SCI pain. Thus, the model may be useful for rapid screening and clinical translation of promising SCI pain therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17935699     DOI: 10.1016/j.brainres.2007.09.013

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  23 in total

1.  Validity of acute and chronic tactile sensory testing after spinal cord injury in rats.

Authors:  Megan Ryan Detloff; Leslie M Clark; Karen J Hutchinson; Anne D Kloos; Lesley C Fisher; D Michele Basso
Journal:  Exp Neurol       Date:  2010-07-17       Impact factor: 5.330

2.  Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Brain Res       Date:  2011-07-26       Impact factor: 3.252

3.  Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Eur J Pharmacol       Date:  2012-03-16       Impact factor: 4.432

4.  Thermal nociception using a modified Hargreaves method in primates and humans.

Authors:  Zhengwen Ma; Yao Li; Yi Ping Zhang; Lisa B E Shields; Qing Xie; Guofeng Yan; Wei Liu; Guoqiang Chen; Ying Zhang; Benedikt Brommer; Xiao-Ming Xu; Yi Lu; Xuejin Chen; Chirstopher B Shields
Journal:  Funct Neurol       Date:  2015 Oct-Dec

5.  Antinociceptive effect of ambroxol in rats with neuropathic spinal cord injury pain.

Authors:  Aldric T Hama; Ann Woodhouse Plum; Jacqueline Sagen
Journal:  Pharmacol Biochem Behav       Date:  2010-08-21       Impact factor: 3.533

6.  Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.

Authors:  Farinaz Nasirinezhad; Stanislava Jergova; James P Pearson; Jacqueline Sagen
Journal:  Neuropharmacology       Date:  2014-12-05       Impact factor: 5.250

7.  Semi-mechanistic modelling of the analgesic effect of gabapentin in the formalin-induced rat model of experimental pain.

Authors:  A Taneja; I F Troconiz; M Danhof; O Della Pasqua
Journal:  Pharm Res       Date:  2013-10-05       Impact factor: 4.200

8.  Ketoprofen produces modality-specific inhibition of pain behaviors in rats after plantar incision.

Authors:  Christina M Spofford; Hazem Ashmawi; Alberto Subieta; Fatima Buevich; Arikha Moses; Max Baker; Timothy J Brennan
Journal:  Anesth Analg       Date:  2009-12       Impact factor: 5.108

9.  Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  J Rehabil Res Dev       Date:  2009

10.  Spinal 5-HT3 receptor mediates nociceptive effect on central neuropathic pain; possible therapeutic role for tropisetron.

Authors:  Farinaz Nasirinezhad; Marjan Hosseini; Zohre Karami; Mahmoud Yousefifard; Autosa Janzadeh
Journal:  J Spinal Cord Med       Date:  2015-09-04       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.